ibuprofen piconol has been researched along with Dermatitis, Atopic in 1 studies
ibuprofen piconol: pyridyl ester of ibuprofen; structure given in first source; RN given refers to cpd without isomeric designation
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
Excerpt | Relevance | Reference |
---|---|---|
" Although topical corticosteroids have been widely utilized in steroid-responsive dermatoses such as AD, their chronic use may be associated with significant side effects." | 1.32 | Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses. ( Hayashi, H; Inoue, Y; Isobe, M; Shiohara, T, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inoue, Y | 1 |
Isobe, M | 1 |
Shiohara, T | 1 |
Hayashi, H | 1 |
1 other study available for ibuprofen piconol and Dermatitis, Atopic
Article | Year |
---|---|
Inhibitory activity of CX-659S, a novel diaminouracil derivative, against the rebound phenomenon following withdrawal of corticosteroid therapy for chronic contact hypersensitivity responses.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Chronic Disease; Dermatitis, Atopic; Der | 2003 |